Skip to content
SentinelMarket desk
Switch to dark mode

엑세스바이오

950130KOSDAQView the 제약 sectorTheme Bio & healthcare

2,030KRWMarket close of 10/21 (Wed)

Down -2.40%-50KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)1,960KRWDown -3.45%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
2,080
High
2,180
Low
2,020
Day range
Day range low 2,020 high 2,180, open 2,080, close 2,030, previous close 2,080
Volume
12×10K shares
244.19 million KRW 0.74× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 2,005 to 5,030 won, 1% up from the low

1% of the way up from the lowest close in 1 year (252 sessions) · -59.6% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-48.94 million KRWOperating income over the last four quarters -48.94 million KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-2.40%usual range
  • Trading value0.7×usual range
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue6.43 million KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +567.5%
    vs. prior quarter
    +74.7%
  • Operating income-15.93 million KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-247.9%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +1,161.6 pp
    vs. prior quarter
    -38.3 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-08-14
2021Q1 163.28 million KRW2026Q2 -15.93 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 24 days
  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.